These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 18884684)

  • 61. Research review: use of activated clotting time to monitor heparin therapy in coronary patients.
    Noureddine SN
    Am J Crit Care; 1995 Jul; 4(4):272-7; quiz 278-9. PubMed ID: 7663590
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Clinical evaluation of a new one-stage clotting assay for heparin and low molecular weight heparins.
    Harenberg J
    J Mal Vasc; 1987; 12 Suppl B():68-70. PubMed ID: 2834495
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Low-dose heparin in gynecologic surgery: effect on blood coagulation tests.
    Levesque G; Samama M; Kher A; Barbier P; Horellou MH; Conard J
    Haemostasis; 1981; 10(2):97-103. PubMed ID: 7461507
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Heparin requirements in patients with acute myocardial infarction.
    Pombo JF; Russell RO; Foster GL
    Arch Intern Med; 1970 Dec; 126(6):1000-3. PubMed ID: 5483592
    [No Abstract]   [Full Text] [Related]  

  • 65. Effect of heparin in nonionic contrast media on blood coagulation and its dose response curve.
    Hwang MH; Piao ZE; Sheu SH
    Cathet Cardiovasc Diagn; 1990 Dec; 21(4):275-7. PubMed ID: 2276203
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Behavior of coagulation time of blood in normal and pathological subjects following intravenous administration of heparin (De Takats test)].
    DOTTI F; BONORA G
    Rass Int Clin Ter; 1950 Jun; 30(12):364-5. PubMed ID: 14781388
    [No Abstract]   [Full Text] [Related]  

  • 67. Effect of high or low protamine dosing on postoperative bleeding following heparin anticoagulation in cardiac surgery. A randomised clinical trial.
    Meesters MI; Veerhoek D; de Lange F; de Vries JW; de Jong JR; Romijn JW; Kelchtermans H; Huskens D; van der Steeg R; Thomas PW; Burtman DT; van Barneveld LJ; Vonk AB; Boer C
    Thromb Haemost; 2016 Aug; 116(2):251-61. PubMed ID: 27277211
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Influence of the concomitant use of heparin on the effects of warfarin during catheter ablation for atrial fibrillation.
    Inada K; Matsuo S; Tokutake K; Yokoyama K; Hioki M; Narui R; Ito K; Tanigawa S; Yamashita S; Tokuda M; Shibayama K; Miyanaga S; Sugimoto K; Yoshimura M; Yamane T
    Heart Vessels; 2016 Mar; 31(3):397-401. PubMed ID: 25471944
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Letter: The heparin thrombin clotting-time.
    Green PJ
    Lancet; 1975 Apr; 1(7910):799. PubMed ID: 48020
    [No Abstract]   [Full Text] [Related]  

  • 70. Kinetics of the anticoagulant effect of heparin.
    Estes JW
    JAMA; 1970 Jun; 212(9):1492-5. PubMed ID: 5467541
    [No Abstract]   [Full Text] [Related]  

  • 71. Problems in laboratory monitoring of heparin dosage.
    Kitchen S
    Br J Haematol; 2000 Nov; 111(2):397-406. PubMed ID: 11122078
    [No Abstract]   [Full Text] [Related]  

  • 72. Prolonged Activated Clotting Time after Protamine Administration Does Not Indicate Residual Heparinization after Cardiopulmonary Bypass in Pediatric Open Heart Surgery.
    Yamamoto T; Wolf HG; Sinzobahamvya N; Asfour B; Hraska V; Schindler E
    Thorac Cardiovasc Surg; 2015 Aug; 63(5):397-403. PubMed ID: 26121380
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Application of the kinetics of heparin to the formulation of dosage schedules.
    Estes JW
    Adv Exp Med Biol; 1975; 52():181-92. PubMed ID: 1124696
    [No Abstract]   [Full Text] [Related]  

  • 74. [Use of low doses of heparin for prophylaxis of postoperative thrombotic complications in gynecological patients].
    Selezneva ND; Strizhakov AN; Makatsariia AD; Savchenko VF
    Akush Ginekol (Mosk); 1982 Nov; (11):27-9. PubMed ID: 7158715
    [No Abstract]   [Full Text] [Related]  

  • 75. INCREASED SENSITIVITY TO HEPARIN FOLLOWING ACUTE MYOCARDIAL INFARCTION.
    DUFAULT C
    Can Med Assoc J; 1965 Jan; 92(1):13-5. PubMed ID: 14216140
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Rational approach to use of heparin during cardiac catheterization in children.
    Grady RM; Eisenberg PR; Bridges ND
    J Am Coll Cardiol; 1995 Mar; 25(3):725-9. PubMed ID: 7860920
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Adjusting heparin infusion rates from the initial response to activated coagulation time.
    Hattersley PG; Mitsuoka JC; Ignoffo RJ; King JH; Musallam NA
    Drug Intell Clin Pharm; 1983 Sep; 17(9):632-4. PubMed ID: 6617481
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Activated clotting time during cardiopulmonary bypass: is repetition necessary during open heart surgery?
    Neema PK; Sinha PK; Rathod RC
    Asian Cardiovasc Thorac Ann; 2004 Mar; 12(1):47-52. PubMed ID: 14977742
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Whole blood coagulation analyzers.
    Health Devices; 1997 Aug; 26(8):296-332. PubMed ID: 9283920
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Real-time measurement of free thrombin: evaluation of the usability of a new thrombin assay for coagulation monitoring during extracorporeal circulation.
    Krajewski S; Krauss S; Kurz J; Neumann B; Schlensak C; Wendel HP
    Thromb Res; 2014 Mar; 133(3):455-63. PubMed ID: 24359968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.